Page last updated: 2024-10-20

trimethyloxamine and Chronic Disease

trimethyloxamine has been researched along with Chronic Disease in 4 studies

trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Wei, H1
Zhao, M1
Huang, M1
Li, C1
Gao, J1
Yu, T1
Zhang, Q1
Shen, X1
Ji, L1
Ni, L1
Zhao, C1
Wang, Z2
Dong, E1
Zheng, L1
Wang, DW1
Trøseid, M1
Ueland, T1
Hov, JR1
Svardal, A1
Gregersen, I1
Dahl, CP1
Aakhus, S1
Gude, E1
Bjørndal, B1
Halvorsen, B1
Karlsen, TH1
Aukrust, P1
Gullestad, L1
Berge, RK1
Yndestad, A1
Tang, WH1
Shrestha, K1
Borowski, AG1
Wu, Y1
Troughton, RW1
Klein, AL1
Hazen, SL1
Aron-Wisnewsky, J1
Clément, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
GutHeart: Targeting Gut Microbiota to Treat Heart Failure[NCT02637167]Phase 2150 participants (Anticipated)Interventional2016-03-11Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for trimethyloxamine and Chronic Disease

ArticleYear
The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
    Nature reviews. Nephrology, 2016, Volume: 12, Issue:3

    Topics: Animals; Biomarkers; Cardiovascular Diseases; Chronic Disease; Diet; Gastrointestinal Microbiome; Hu

2016

Other Studies

3 other studies available for trimethyloxamine and Chronic Disease

ArticleYear
FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population.
    Frontiers of medicine, 2022, Volume: 16, Issue:2

    Topics: Carnitine; Choline; Chronic Disease; Heart Failure; Humans; Methylamines; Oxygenases; Prospective St

2022
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Journal of internal medicine, 2015, Volume: 277, Issue:6

    Topics: Aged; Betaine; Biomarkers; Choline; Chronic Disease; Female; Heart Failure; Humans; Intestinal Mucos

2015
Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Journal of cardiac failure, 2015, Volume: 21, Issue:2

    Topics: Adult; Aged; Betaine; Biomarkers; Blood Pressure; Choline; Chronic Disease; Cohort Studies; Female;

2015